DDMS

• Description:

  DDMS (Dibromo-dodecenyl-methylsulfimide) is a selective 20-HETE production inhibitor. DDMS attenuates the vasodilatory response to sodium nitroprusside (SNP) [1].

• Product Name Alternative:

  Dibromo-dodecenyl-methylsulfimide

• UNSPSC:

  12352211

• Hazard Statement:

  H302, H314

• Target:

  Cytochrome P450

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/ddms.html

• Purity:

  99.19

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  Br/C(Br)=C\CCCCCCCCCC(NS(=O)(C)=O)=O

• Molecular Formula:

  C13H23Br2NO3S

• Molecular Weight:

  433.20

• Precautions:

  H302, H314

• References & Citations:

  [1]Alonso-Galicia M, et al. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension. 1997 Jan;29 (1 Pt 2) :320-5.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [206052-03-1]